Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Change in Inventory (2021 - 2023)

Historic Change in Inventory for ADC Therapeutics (ADCT) over the last 3 years, with Q4 2023 value amounting to -$167000.0.

  • ADC Therapeutics' Change in Inventory fell 10172.93% to -$167000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $5.7 million, marking a year-over-year decrease of 4081.44%. This contributed to the annual value of $3.7 million for FY2024, which is 3473.39% down from last year.
  • Per ADC Therapeutics' latest filing, its Change in Inventory stood at -$167000.0 for Q4 2023, which was down 10172.93% from $3.5 million recorded in Q3 2023.
  • In the past 5 years, ADC Therapeutics' Change in Inventory registered a high of $9.7 million during Q4 2022, and its lowest value of -$167000.0 during Q4 2023.
  • In the last 3 years, ADC Therapeutics' Change in Inventory had a median value of -$174.0 in 2021 and averaged $1.5 million.
  • Data for ADC Therapeutics' Change in Inventory shows a peak YoY increase of 46821173.05% (in 2022) and a maximum YoY decrease of 2671428.57% (in 2022) over the last 5 years.
  • Over the past 3 years, ADC Therapeutics' Change in Inventory (Quarter) stood at -$2063.0 in 2021, then skyrocketed by 468211.73% to $9.7 million in 2022, then crashed by 101.73% to -$167000.0 in 2023.
  • Its Change in Inventory was -$167000.0 in Q4 2023, compared to $3.5 million in Q3 2023 and $2.1 million in Q2 2023.